Home/ Stocks/ CDIO

Cardio Diagnostics Holdings Inc. Common stock

CDIO XNAS

$1.79 +0.13 (+7.83%) ▲ 15-min delayed

Open

$1.57

High

$1.80

Low

$1.57

Volume

6.4K

Market Cap

$4.91M

About Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.

Sector: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES Employees: 17 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$2.7K	$-1,788,158	$-0.63
FY 2025	$14.8K	$-6,498,167	$-3.71
Q3 2025	$2.9K	$-1,714,536	$-0.98
Q2 2025	$7.5K	$-1,683,199	$-0.97

TickerDaily Coverage

Why Is Cardio Diagnostics Holdings Inc. Common Stock (CDIO) Stock Up 45.2% Today?

Market News David Brooks · Feb 27, 2026

Cardio Diagnostics Holdings Inc. Common Stock (CDIO) ripped 45.2% higher to $5.22 on volume of...

Why Is Cardio Diagnostics Holdings Inc. Common Stock (CDIO) Stock Up 45.0% Today?

Penny Stocks Marcus Rivera · Feb 25, 2026

Cardio Diagnostics Holdings (CDIO) ripped 45.02% higher to $4.79 on massive volume of 8.3M...

View All Coverage →

Get CDIO Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Cardio Diagnostics Holdings Inc. Common stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.